Global Apomorphine Hydrochloride 麻豆原创 Research Report 2023

Publication ID:

PB501232624

Publication Date:

January 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and 伪-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
Highlights
The global Apomorphine Hydrochloride market was valued at US$ 277.7 million in 2022 and is anticipated to reach US$ 364.1 million by 2029, witnessing a CAGR of 3.9% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
麻豆原创 competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride.
The Apomorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Apomorphine Hydrochloride market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apomorphine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Segment by Type
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
Segment by Application
Parkinson Disease
Erectile Dysfunction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apomorphine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Apomorphine Hydrochloride 麻豆原创 Overview
1.1 Product Overview and Scope of Apomorphine Hydrochloride
1.2 Apomorphine Hydrochloride Segment by Type
1.2.1 Global Apomorphine Hydrochloride 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Thinfilm
1.2.5 Nasal Powder (Pipeline)
1.3 Apomorphine Hydrochloride Segment by Application
1.3.1 Global Apomorphine Hydrochloride 麻豆原创 Value by Application: (2023-2029)
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Global Apomorphine Hydrochloride 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Apomorphine Hydrochloride Revenue 2018-2029
1.4.2 Global Apomorphine Hydrochloride Sales 2018-2029
1.4.3 Global Apomorphine Hydrochloride 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Apomorphine Hydrochloride 麻豆原创 Competition by Manufacturers
2.1 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Apomorphine Hydrochloride Average Price by Manufacturers (2018-2023)
2.4 Global Apomorphine Hydrochloride Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Apomorphine Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Apomorphine Hydrochloride, Product Type & Application
2.7 Apomorphine Hydrochloride 麻豆原创 Competitive Situation and Trends
2.7.1 Apomorphine Hydrochloride 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Apomorphine Hydrochloride Players 麻豆原创 Share by Revenue
2.7.3 Global Apomorphine Hydrochloride 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Apomorphine Hydrochloride Retrospective 麻豆原创 Scenario by Region
3.1 Global Apomorphine Hydrochloride 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Apomorphine Hydrochloride Global Apomorphine Hydrochloride Sales by Region: 2018-2029
3.2.1 Global Apomorphine Hydrochloride Sales by Region: 2018-2023
3.2.2 Global Apomorphine Hydrochloride Sales by Region: 2024-2029
3.3 Global Apomorphine Hydrochloride Global Apomorphine Hydrochloride Revenue by Region: 2018-2029
3.3.1 Global Apomorphine Hydrochloride Revenue by Region: 2018-2023
3.3.2 Global Apomorphine Hydrochloride Revenue by Region: 2024-2029
3.4 North America Apomorphine Hydrochloride 麻豆原创 Facts & Figures by Country
3.4.1 North America Apomorphine Hydrochloride 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Apomorphine Hydrochloride Sales by Country (2018-2029)
3.4.3 North America Apomorphine Hydrochloride Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Apomorphine Hydrochloride 麻豆原创 Facts & Figures by Country
3.5.1 Europe Apomorphine Hydrochloride 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Apomorphine Hydrochloride Sales by Country (2018-2029)
3.5.3 Europe Apomorphine Hydrochloride Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Apomorphine Hydrochloride 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Apomorphine Hydrochloride 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Apomorphine Hydrochloride Sales by Country (2018-2029)
3.6.3 Asia Pacific Apomorphine Hydrochloride Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Apomorphine Hydrochloride 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Apomorphine Hydrochloride 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Apomorphine Hydrochloride Sales by Country (2018-2029)
3.7.3 Latin America Apomorphine Hydrochloride Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Apomorphine Hydrochloride 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Apomorphine Hydrochloride 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Apomorphine Hydrochloride Sales by Country (2018-2029)
3.8.3 Middle East and Africa Apomorphine Hydrochloride Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Apomorphine Hydrochloride Sales by Type (2018-2029)
4.1.1 Global Apomorphine Hydrochloride Sales by Type (2018-2023)
4.1.2 Global Apomorphine Hydrochloride Sales by Type (2024-2029)
4.1.3 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Apomorphine Hydrochloride Revenue by Type (2018-2029)
4.2.1 Global Apomorphine Hydrochloride Revenue by Type (2018-2023)
4.2.2 Global Apomorphine Hydrochloride Revenue by Type (2024-2029)
4.2.3 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Apomorphine Hydrochloride Price by Type (2018-2029)
5 Segment by Application
5.1 Global Apomorphine Hydrochloride Sales by Application (2018-2029)
5.1.1 Global Apomorphine Hydrochloride Sales by Application (2018-2023)
5.1.2 Global Apomorphine Hydrochloride Sales by Application (2024-2029)
5.1.3 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Apomorphine Hydrochloride Revenue by Application (2018-2029)
5.2.1 Global Apomorphine Hydrochloride Revenue by Application (2018-2023)
5.2.2 Global Apomorphine Hydrochloride Revenue by Application (2024-2029)
5.2.3 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Apomorphine Hydrochloride Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Supernus Pharmaceuticals
6.1.1 Supernus Pharmaceuticals Corporation Information
6.1.2 Supernus Pharmaceuticals Description and Business Overview
6.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
6.1.5 Supernus Pharmaceuticals Recent Developments/Updates
6.2 Britannia Pharmaceuticals STADA
6.2.1 Britannia Pharmaceuticals STADA Corporation Information
6.2.2 Britannia Pharmaceuticals STADA Description and Business Overview
6.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
6.2.5 Britannia Pharmaceuticals STADA Recent Developments/Updates
6.3 Ever Pharma
6.3.1 Ever Pharma Corporation Information
6.3.2 Ever Pharma Description and Business Overview
6.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
6.3.5 Ever Pharma Recent Developments/Updates
6.4 Evolan Pharma AB (PharmSwed)
6.4.1 Evolan Pharma AB (PharmSwed) Corporation Information
6.4.2 Evolan Pharma AB (PharmSwed) Description and Business Overview
6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments/Updates
6.5 Tianjin Tianwei Pharmaceutical
6.5.1 Tianjin Tianwei Pharmaceutical Corporation Information
6.5.2 Tianjin Tianwei Pharmaceutical Description and Business Overview
6.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
6.5.5 Tianjin Tianwei Pharmaceutical Recent Developments/Updates
6.6 Sunovion
6.6.1 Sunovion Corporation Information
6.6.2 Sunovion Description and Business Overview
6.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
6.6.5 Sunovion Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Apomorphine Hydrochloride Industry Chain Analysis
7.2 Apomorphine Hydrochloride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Apomorphine Hydrochloride Production Mode & Process
7.4 Apomorphine Hydrochloride Sales and 麻豆原创ing
7.4.1 Apomorphine Hydrochloride Sales Channels
7.4.2 Apomorphine Hydrochloride Distributors
7.5 Apomorphine Hydrochloride Customers
8 Apomorphine Hydrochloride 麻豆原创 Dynamics
8.1 Apomorphine Hydrochloride Industry Trends
8.2 Apomorphine Hydrochloride 麻豆原创 Drivers
8.3 Apomorphine Hydrochloride 麻豆原创 Challenges
8.4 Apomorphine Hydrochloride 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.